Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01926184 · ClinicalTrials.gov registry record · NA
RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01926184 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 110 participants.
The verdict
NCT01926184, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
In the era of HIV treatment as prevention (TasP), efforts are needed to identify evidence-based combination prevention approaches that achieve greater decreases HIV viral load among populations that are more likely to engage in HIV transmission risk behavior. Because methamphetamine-using men who have sex with men (MSM) are at greater risk for acquiring and transmitting HIV, interventions targeting stimulant use in this population of high-risk men could boost the effectiveness of TasP. At present, only conditional cash transfer approaches such as contingency management (CM) have demonstrated short- term efficacy in reducing stimulant use among substance-using MSM who are not actively seeking formal treatment. The proposed RCT will examine the efficacy of a positive affect intervention that is designed to optimize the effectiveness of CM to achieve long-term reductions in stimulant use and HIV viral load in this population. the team will examine the efficacy of this integrative intervention in a randomized controlled trial (RCT) with 110 HIV-positive, methamphetamine-using MSM. After enrolling in CM, participants will be randomized to receive either: 1) the positive affect intervention; or 2) a attention-matched control condition. Follow-up data will be collected at 3, 6, 12, and 15 months post-randomization. This RCT will provide an opportunity to examine the efficacy of an integrative intervention designed to promote long-term reductions in HIV viral load as the primary outcome. Secondary outcomes that will be examined include: increases positive affect, reductions in stimulant use, improvements in T-helper (CD4+) count, unsuppressed viral load, and decreases HIV transmission risk behavior. Identifying an efficacious intervention approach to decrease HIV viral load among methamphetamine-using MSM would substantially support the goals of the National HIV/AIDS Strategy to reduce HIV incidence and mitigate HIV-related health disparities.
Interventions
- BEHAVIORAL Contingency Management (CM)
- BEHAVIORAL Affect Regulation Treatment to Enhance Meth Intervention Success (ARTEMIS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-10-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01926184
The ClinicalTrials.gov registry entry for NCT01926184 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Contingency Management (CM) is the first listed.
NCT01926184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01926184 about?
NCT01926184 is a clinical study titled "RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users". In the era of HIV treatment as prevention (TasP), efforts are needed to identify evidence-based combination prevention approaches that achieve greater decreases HIV viral load among populations that are more likely to engage in HIV transmission risk behavior. Because methamphetamine-using men who ha...
What is the current status of trial NCT01926184?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2013-01. Estimated completion is 2018-10-08.
What interventions are being tested in trial NCT01926184?
The interventions under investigation include: Contingency Management (CM) (BEHAVIORAL), Affect Regulation Treatment to Enhance Meth Intervention Success (ARTEMIS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01926184?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.